piribedil has been researched along with Adjustment Disorders in 2 studies
Piribedil: A dopamine D2 agonist. It is used in the treatment of parkinson disease, particularly for alleviation of tremor. It has also been used for circulatory disorders and in other applications as a D2 agonist.
Adjustment Disorders: Maladaptive reactions to identifiable psychosocial stressors occurring within a short time after onset of the stressor. They are manifested by either impairment in social or occupational functioning or by symptoms (depression, anxiety, etc.) that are in excess of a normal and expected reaction to the stressor.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Oules, MJ | 1 |
| Boscredon, J | 1 |
| Shopsin, B | 1 |
| Gershon, S | 1 |
2 other studies available for piribedil and Adjustment Disorders
| Article | Year |
|---|---|
[Clinical study of cerebral dopaminergic mechanisms: the action of piribedil in psychiatry. Initial results].
Topics: Adjustment Disorders; Aged; Dementia; Depression; Humans; Middle Aged; Piperazines; Piribedil | 1979 |
Dopamine receptor stimulation in the treatment of depression: piribedil (ET-495).
Topics: Adjustment Disorders; Adult; Aged; Amphetamines; Anger; Antidepressive Agents; Bipolar Disorder; Bro | 1978 |